IL HB3454 | 2025-2026 | 104th General Assembly

Status

Sponsorship: Partisan Bill (Democrat 11)
Status: Enrolled on May 31 2026 - 75% progression
Action: 2026-06-26 - Sent to the Governor
Text: Latest bill text (Enrolled) [HTML]

Summary

Amends various Acts to change references from "epinephrine auto-injector" or "epinephrine injector" to "FDA approved epinephrine delivery device or product". Changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

EPINEPHRINE DELIVERY DEVICE

Sponsors


History

DateChamberAction
2026-06-26HouseSent to the Governor
2026-05-31HousePassed Both Houses
2026-05-31HouseHouse Concurs
2026-05-31HouseSenate Floor Amendment No. 2 House Concurs 116-000-000
2026-05-29HouseSenate Floor Amendment No. 2 Motion to Concur Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 013-000-000
2026-05-29HouseSenate Floor Amendment No. 2 Motion to Concur Rules Referred to Prescription Drug Affordability & Accessibility Committee
2026-05-29HouseAdded Chief Co-Sponsor Rep. Natalie A. Manley
2026-05-29HouseSenate Floor Amendment No. 2 Motion to Concur Referred to Rules Committee
2026-05-29HouseSenate Floor Amendment No. 2 Motion Filed Concur Rep. Joyce Mason
2026-05-28HousePlaced on Calendar Order of Concurrence Senate Amendment(s) 2
2026-05-28HouseArrived in House
2026-05-28SenateAdded as Alternate Co-Sponsor Sen. Mary Edly-Allen
2026-05-28SenateThird Reading - Passed; 059-000-000
2026-05-28SenatePlaced on Calendar Order of 3rd Reading
2026-05-28SenateSenate Floor Amendment No. 2 Adopted; Glowiak-Hilton
2026-05-28SenateRecalled to Second Reading
2026-05-22SenateRule 2-10 Third Reading Deadline Established As May 31, 2026
2026-05-19SenateSenate Floor Amendment No. 2 Be Approved for Consideration Assignments
2026-05-18SenateSenate Floor Amendment No. 2 Referred to Assignments
2026-05-18SenateSenate Floor Amendment No. 2 Filed with Secretary by Sen. Suzy Glowiak Hilton
2026-05-14SenatePlaced on Calendar Order of 3rd Reading May 18, 2026
2026-05-14SenateSecond Reading
2026-05-06SenatePlaced on Calendar Order of 2nd Reading May 7, 2026
2026-05-06SenateDo Pass Insurance; 009-000-000
2026-05-06SenateSenate Committee Amendment No. 1 Referred to Assignments
2026-05-06SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Suzy Glowiak Hilton
2026-04-28SenateAssigned to Insurance
2026-03-26SenateReferred to Assignments
2026-03-26SenateFirst Reading
2026-03-26SenateChief Senate Sponsor Sen. Suzy Glowiak Hilton
2026-03-09HouseAdded Chief Co-Sponsor Rep. Janet Yang Rohr
2026-03-02HouseAdded Co-Sponsor Rep. Michelle Mussman
2026-02-26SenatePlaced on Calendar Order of First Reading March 3, 2026
2026-02-26SenateArrive in Senate
2026-02-25HouseThird Reading - Short Debate - Passed 105-000-000
2026-02-25HousePlaced on Calendar Order of 3rd Reading - Short Debate
2026-02-13HousePlaced on Calendar 2nd Reading - Short Debate
2026-02-11HouseApproved for Consideration Rules Committee; 005-000-000
2026-01-21HouseAdded Chief Co-Sponsor Rep. Martha Deuter
2025-04-11HouseRule 19(a) / Re-referred to Rules Committee
2025-04-08HouseAdded Co-Sponsor Rep. Camille Y. Lilly
2025-03-26HouseHeld on Calendar Order of Second Reading - Short Debate
2025-03-26HouseSecond Reading - Short Debate
2025-03-26HouseAdded Co-Sponsor Rep. Dagmara Avelar
2025-03-26HouseAdded Co-Sponsor Rep. Harry Benton
2025-03-26HouseAdded Co-Sponsor Rep. Jawaharial Williams
2025-03-20HousePlaced on Calendar 2nd Reading - Short Debate
2025-03-19HouseDo Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000
2025-03-11HouseAssigned to Prescription Drug Affordability & Accessibility Committee
2025-02-18HouseReferred to Rules Committee
2025-02-18HouseFirst Reading
2025-02-07HouseFiled with the Clerk by Rep. Joyce Mason

Code Citations

ChapterArticleSectionCitation TypeStatute Text
105522-30Amended CodeCitation Text
20261040Amended CodeCitation Text
2155356z.33Amended CodeCitation Text
2256065Amended CodeCitation Text
410271Amended CodeCitation Text
4102710Amended CodeCitation Text
4102715Amended CodeCitation Text
4102720Amended CodeCitation Text
410275Amended CodeCitation Text
41060710Amended CodeCitation Text
4106203.21Amended CodeCitation Text
5070510.19Amended CodeCitation Text

Illinois State Sources

TypeSource
Summaryhttps://www.ilga.gov/Legislation/BillStatus?DocNum=3454&GAID=18&DocTypeID=HB&SessionID=114&GA=104
Texthttps://www.ilga.gov/Legislation/BillStatus/FullText?LegDocId=201883&DocName=10400HB3454&DocNum=3454&DocTypeID=HB&LegID=162095&GAID=18&SessionID=114&SpecSess=&Session=
Texthttps://www.ilga.gov/Legislation/BillStatus/FullText?LegDocId=201883&DocName=10400HB3454eng&DocNum=3454&DocTypeID=HB&LegID=162095&GAID=18&SessionID=114&SpecSess=&Session=
Texthttps://www.ilga.gov/Legislation/BillStatus/FullText?LegDocId=201883&DocName=10400HB3454enr&DocNum=3454&DocTypeID=HB&LegID=162095&GAID=18&SessionID=114&SpecSess=&Session=
Amendmenthttps://www.ilga.gov/Legislation/BillStatus/FullText?LegDocId=210866&DocName=10400HB3454sam001&DocNum=3454&DocTypeID=HB&LegID=162095&GAID=18&SessionID=114&SpecSess=&Session=
Amendmenthttps://www.ilga.gov/Legislation/BillStatus/FullText?LegDocId=211111&DocName=10400HB3454sam002&DocNum=3454&DocTypeID=HB&LegID=162095&GAID=18&SessionID=114&SpecSess=&Session=

feedback